Cargando…

Further Optimization of the Reliability of the 28-Joint Disease Activity Score in Patients with Early Rheumatoid Arthritis

BACKGROUND: The 28-joint Disease Activity Score (DAS28) combines scores on a 28-tender and swollen joint count (TJC28 and SJC28), a patient-reported measure for general health (GH), and an inflammatory marker (either the erythrocyte sedimentation rate [ESR] or the C-reactive protein [CRP]) into a co...

Descripción completa

Detalles Bibliográficos
Autores principales: Siemons, Liseth, ten Klooster, Peter M., Vonkeman, Harald E., van de Laar, Mart A. F. J., Glas, Cees A. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067329/
https://www.ncbi.nlm.nih.gov/pubmed/24955759
http://dx.doi.org/10.1371/journal.pone.0100544
_version_ 1782322275797696512
author Siemons, Liseth
ten Klooster, Peter M.
Vonkeman, Harald E.
van de Laar, Mart A. F. J.
Glas, Cees A. W.
author_facet Siemons, Liseth
ten Klooster, Peter M.
Vonkeman, Harald E.
van de Laar, Mart A. F. J.
Glas, Cees A. W.
author_sort Siemons, Liseth
collection PubMed
description BACKGROUND: The 28-joint Disease Activity Score (DAS28) combines scores on a 28-tender and swollen joint count (TJC28 and SJC28), a patient-reported measure for general health (GH), and an inflammatory marker (either the erythrocyte sedimentation rate [ESR] or the C-reactive protein [CRP]) into a composite measure of disease activity in rheumatoid arthritis (RA). This study examined the reliability of the DAS28 in patients with early RA using principles from generalizability theory and evaluated whether it could be increased by adjusting individual DAS28 component weights. METHODS: Patients were drawn from the DREAM registry and classified into a “fast response” group (N = 466) and “slow response” group (N = 80), depending on their pace of reaching remission. Composite reliabilities of the DAS28-ESR and DAS28-CRP were determined with the individual components' reliability, weights, variances, error variances, correlations and covariances. Weight optimization was performed by minimizing the error variance of the index. RESULTS: Composite reliabilities of 0.85 and 0.86 were found for the DAS28-ESR and DAS28-CRP, respectively, and were approximately equal across patients groups. Component reliabilities, however, varied widely both within and between sub-groups, ranging from 0.614 for GH (“slow response” group) to 0.912 for ESR (“fast response” group). Weight optimization increased composite reliability even further. In the total and “fast response” groups, this was achieved mostly by decreasing the weight of the TJC28 and GH. In the “slow response” group, though, the weights of the TJC28 and SJC28 were increased, while those of the inflammatory markers and GH were substantially decreased. CONCLUSIONS: The DAS28-ESR and the DAS28-CRP are reliable instruments for assessing disease activity in early RA and reliability can be increased even further by adjusting component weights. Given the low reliability and weightings of the general health component across subgroups it is recommended to explore alternative patient-reported outcome measures for inclusion in the DAS28.
format Online
Article
Text
id pubmed-4067329
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40673292014-06-25 Further Optimization of the Reliability of the 28-Joint Disease Activity Score in Patients with Early Rheumatoid Arthritis Siemons, Liseth ten Klooster, Peter M. Vonkeman, Harald E. van de Laar, Mart A. F. J. Glas, Cees A. W. PLoS One Research Article BACKGROUND: The 28-joint Disease Activity Score (DAS28) combines scores on a 28-tender and swollen joint count (TJC28 and SJC28), a patient-reported measure for general health (GH), and an inflammatory marker (either the erythrocyte sedimentation rate [ESR] or the C-reactive protein [CRP]) into a composite measure of disease activity in rheumatoid arthritis (RA). This study examined the reliability of the DAS28 in patients with early RA using principles from generalizability theory and evaluated whether it could be increased by adjusting individual DAS28 component weights. METHODS: Patients were drawn from the DREAM registry and classified into a “fast response” group (N = 466) and “slow response” group (N = 80), depending on their pace of reaching remission. Composite reliabilities of the DAS28-ESR and DAS28-CRP were determined with the individual components' reliability, weights, variances, error variances, correlations and covariances. Weight optimization was performed by minimizing the error variance of the index. RESULTS: Composite reliabilities of 0.85 and 0.86 were found for the DAS28-ESR and DAS28-CRP, respectively, and were approximately equal across patients groups. Component reliabilities, however, varied widely both within and between sub-groups, ranging from 0.614 for GH (“slow response” group) to 0.912 for ESR (“fast response” group). Weight optimization increased composite reliability even further. In the total and “fast response” groups, this was achieved mostly by decreasing the weight of the TJC28 and GH. In the “slow response” group, though, the weights of the TJC28 and SJC28 were increased, while those of the inflammatory markers and GH were substantially decreased. CONCLUSIONS: The DAS28-ESR and the DAS28-CRP are reliable instruments for assessing disease activity in early RA and reliability can be increased even further by adjusting component weights. Given the low reliability and weightings of the general health component across subgroups it is recommended to explore alternative patient-reported outcome measures for inclusion in the DAS28. Public Library of Science 2014-06-23 /pmc/articles/PMC4067329/ /pubmed/24955759 http://dx.doi.org/10.1371/journal.pone.0100544 Text en © 2014 Siemons et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Siemons, Liseth
ten Klooster, Peter M.
Vonkeman, Harald E.
van de Laar, Mart A. F. J.
Glas, Cees A. W.
Further Optimization of the Reliability of the 28-Joint Disease Activity Score in Patients with Early Rheumatoid Arthritis
title Further Optimization of the Reliability of the 28-Joint Disease Activity Score in Patients with Early Rheumatoid Arthritis
title_full Further Optimization of the Reliability of the 28-Joint Disease Activity Score in Patients with Early Rheumatoid Arthritis
title_fullStr Further Optimization of the Reliability of the 28-Joint Disease Activity Score in Patients with Early Rheumatoid Arthritis
title_full_unstemmed Further Optimization of the Reliability of the 28-Joint Disease Activity Score in Patients with Early Rheumatoid Arthritis
title_short Further Optimization of the Reliability of the 28-Joint Disease Activity Score in Patients with Early Rheumatoid Arthritis
title_sort further optimization of the reliability of the 28-joint disease activity score in patients with early rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067329/
https://www.ncbi.nlm.nih.gov/pubmed/24955759
http://dx.doi.org/10.1371/journal.pone.0100544
work_keys_str_mv AT siemonsliseth furtheroptimizationofthereliabilityofthe28jointdiseaseactivityscoreinpatientswithearlyrheumatoidarthritis
AT tenkloosterpeterm furtheroptimizationofthereliabilityofthe28jointdiseaseactivityscoreinpatientswithearlyrheumatoidarthritis
AT vonkemanharalde furtheroptimizationofthereliabilityofthe28jointdiseaseactivityscoreinpatientswithearlyrheumatoidarthritis
AT vandelaarmartafj furtheroptimizationofthereliabilityofthe28jointdiseaseactivityscoreinpatientswithearlyrheumatoidarthritis
AT glasceesaw furtheroptimizationofthereliabilityofthe28jointdiseaseactivityscoreinpatientswithearlyrheumatoidarthritis